Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series
©Copyright M.N. Chitasombat and P. Niparuck, 2018. Mucormycosis is a life-threatening disease requiring multimodal treatment with antifungals and surgery. The mortality rate remains high, prompting consideration of alternative treatment strategies. Deferiprone has in vitro activity against Mucorales...
Saved in:
Main Authors: | Maria N. Chitasombat, Pimjai Niparuck |
---|---|
Other Authors: | Faculty of Medicine, Ramathibodi Hospital, Mahidol University |
Format: | Article |
Published: |
2019
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/47132 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Treatment of mucormycosis in transplant patients: Role of surgery and of old and new antifungal agents
by: Maria N. Chitasombat, et al.
Published: (2018) -
Invasive mold infection in kidney transplant recipients: Observation of early-onset mucormycosis
by: M. Chayakulkeeree, et al.
Published: (2018) -
Mucormycosis in severely burned patients. Report of two cases with extensive destructive lesions
by: C. Chuntrasakul, et al.
Published: (2018) -
Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
by: Pannee Leelawattanachai, et al.
Published: (2020) -
Case report: Lung ultrasound for the guidance of adjunctive therapies in two invasively ventilated patients with COVID-19
by: Charalampos Pierrakos, et al.
Published: (2020)